Fol. Biol. 2013, 59, 32-40
https://doi.org/10.14712/fb2013059010032
Galantamine as a Preventive of Diisopropylphosphorofluoridate Toxicity Effects in Rat Brain
References
1. , E. X., Santos, M. D., Alkondon, M., Pereira, E. F, Maelicke, A. (2001) Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 15 (Suppl 1), S19-S25.
<https://doi.org/10.1097/00002093-200108001-00004>
2. , E. X., Pereira, E. F., Aracava, Y., Fawcett, W. P., Oliveira, M., Randall, W. R., Hamilton, T. A., Kan, R. K., Romano, J. A. Jr., Adler, M. (2006) Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc. Natl. Acad. Sci. USA 103, 13263-13264.
<https://doi.org/10.1073/pnas.0605370103>
3. , C., Lamproglou, I., Barbier, L., Fauquette, W., Zoppe, A., Viret, R., Diserbo, M. (2009) Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. Behav. Brain Res. 203, 207-214.
<https://doi.org/10.1016/j.bbr.2009.05.002>
4. , P., Foquin, A., Kamenka, J. M., Rondouin, G., Lerner-Natoli, M., de Groot, D. M., Lallement, G. (2001) Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity. Neurotoxicology 22, 13-28.
<https://doi.org/10.1016/S0161-813X(00)00016-4>
5. , M. (2003) Clinical pharmacokinetics of galantamine. Clin Pharmacokinet. 42, 1383-1392.
<https://doi.org/10.2165/00003088-200342150-00005>
6. , C. J., Herr, D. W., Gennings, C., Graff, J. E., McMurray, M., Stork, L., Coffey, T., Hamm, A., Mack, C. M. (2006) Thermoregulatory response to an organophosphate and carbamate insecticide mixture: testing the assumption of dose-additivity. Toxicology 5, 1-13.
<https://doi.org/10.1016/j.tox.2005.08.014>
7. , R. P., Damodaran, T. V., Abou-Donia, M. B. (2000) C-fos mRNA induction in the central and peripheral nervous systems of diisopropyl phosphorofluoridate (DFP)treated hens. Neurochem. Res. 25, 27-34.
<https://doi.org/10.1023/A:1007580702080>
8. , D. S. (2002) Central anticholinergics to treat nerveagent poisoning. Lancet 19, 265-266.
<https://doi.org/10.1016/S0140-6736(02)07434-2>
9. , D. S., Davis, J. M., Overstreet, D. H. (2004) Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study. Pharmacol. Biochem. Behav. 77, 337-343.
<https://doi.org/10.1016/j.pbb.2003.11.012>
10. , D. S., Davis, J. M., Overstreet, D. H. (2005) Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: A potential nerve agent treatment. Pharmacol. Biochem. Behav. 8, 917-922.
<https://doi.org/10.1016/j.pbb.2005.06.017>
11. , J. R., Hurst, G. G., Dunn, M. A. (1991) Pyridostigmine used as a nerve agent pre-treatment under wartime conditions. JAMA 266, 693-695.
<https://doi.org/10.1001/jama.1991.03470050093029>
12. , A. E., Bakshi, V. P., Delfs, J. M., Lang, C. G. (1989) Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology (Berl.) 99, 542-549.
<https://doi.org/10.1007/BF00589906>
13. G. G., Friendenwald, J. S. (1949) A histochemical method for localizing acetylcholinesterase activity. Exp. Biol. Med. 70, 617-622.
<https://doi.org/10.3181/00379727-70-17013>
14. , G., Foquin, A., Dorandeu, F., Baubichon, D., Carpentier, P. (2001) Subchronic administration of various pre-treatments of nerve gas poisoning: II. Compared efficacy against soman toxicity. Drug Chem. Toxicol. 24, 165-180.
<https://doi.org/10.1081/DCT-100102608>
15. , L., Inns, R. H., Rylands, J. M. (1985) Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5, 225-231.
<https://doi.org/10.1016/0272-0590(85)90132-0>
16. ,Y. Q., Tang, X. C. (2004) Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neurosci. Lett. 6, 56-59.
<https://doi.org/10.1016/j.neulet.2003.12.071>
17. , G. S., Snel, C. A., Hendrickx, J., Verhaeghe, T., Le Jeune, L., Bode, W., van Beijsterveldt, L., Lavrijsen, K., Leempoels, J., Van Osselaer, N., Van Peer, A., Meuldermans, W. (2002) The metabolism and excretion of galantamine in rats, dogs, and humans. Drug Metab Dispos. 30, 553-563.
<https://doi.org/10.1124/dmd.30.5.553>
18. , A. (2000) Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 11 (Suppl 1), 11-18.
<https://doi.org/10.1159/000051227>
19. , J. H. Jr., Shih, T. M. (1993) Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17, 203-215.
<https://doi.org/10.1016/S0149-7634(05)80151-4>
20. , J. H. Jr., Shih, T. M.(1997)Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21, 559-579.
<https://doi.org/10.1016/S0149-7634(96)00050-4>
21. , S. A., Blick, D. W., Kerenyi, S. Z., Murphy, M. R. (1993) Efficacy of physostigmine as a pre-treatment for organophosphate poisoning. Pharmacol. Biochem. Behav. 442, 343-347.
<https://doi.org/10.1016/0091-3057(93)90472-6>
22. , J., Verhaeghe, T., Willems, B., Bode, W., Lavrijsen, K., Meuldermans, W. (2003) Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Arzneimittelforschung 53, 486-495.
23. , H., Kosasa, T., Kuriya, Y., Yamanishi, Y. (2001) Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats. Eur. J. Pharmacol. 415, 157-164.
<https://doi.org/10.1016/S0014-2999(01)00824-X>
24. , M. M., Pregelj, P., Zivin, M. (2010) Donepezil inhibits diisopropylfluorophosphate-induced seizures and up-regulation of synaptotagmin 4 mRNA. Folia Biol. (Praha) 56, 256-262.
25. , Y., Belkin, M. (1997) The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 18, 183-185.
<https://doi.org/10.1016/S0165-6147(97)89540-5>
26. Taylor, P. (1996) Anticholinesterase agents. In: The Pharmacological Basis of Therapeutics, eds. Hardman, J. G., Limbird, L. E., Molinoff, P. B., Luddon, R. W., Gilman, A. G., pp. 131-149, McGraw-Hill, New York.
27. , L., Geerts, R., Verhaeghe, T., Willems, B., Bode, W., Lavrijsen, K., Meuldermans, W. (2004) Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat. Arzneimittelforschung 54, 85-94.
28. , P., Aas, P., Haider, T., Fonnum, F. (1993) Effect of pyridostigmine pre-treatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure. Arch. Toxicol. 67, 212-219.
<https://doi.org/10.1007/BF01973310>
29. Watson, A., Opresko, D., Young, R., Hauschild, V., King, J., Bakshi, K. (2009) Organophosphate nerve agents. In: Handbook of Toxicology of Chemical Warfare Agents, ed. Gupta, R. C., pp. 43-67, Academic Press/Elsevier, London.
30. , D. Y., Wang, L. X., Pei, S. Q. (1981) The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo. Fundam. Appl. Toxicol. 1, 217-221.
31. , M., Milatovic, D., Dettbarn, W. D. (1999) Nitrone spin trapping compound N-tert-butyl-alpha-phenylnitrone prevents seizures induced by anticholinesterases. Brain Res. 850, 63-72.
<https://doi.org/10.1016/S0006-8993(99)02101-0>
